Ask Warren

Hanmi Science

008930 · KOSPI · ₩008930 · 한미사이언스

₩43,100▲ ₩900 (2.13%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • Investor relations (IR) event기업설명회(IR)개최(안내공시)

    Predicted impact: Low

    Oct 30, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최(안내공시)

    Predicted impact: Low

    Oct 30, 2026Open on DART
  • Change in largest shareholder's holdings최대주주등소유주식변동신고서

    Predicted impact: Low

    Oct 30, 2026Open on DART
  • Share cancellation decision주식소각결정(자회사의 주요경영사항)

    Predicted impact: Medium

    Share cancellation by subsidiary; size not given, so impact on parent uncertain.

    Oct 30, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항(자회사의 주요경영사항) (파브리병 치료제(LAGLA) 기술이전 계약 체결)

    Predicted impact: Medium

    Subsidiary signed a Fabry disease drug tech-transfer deal; value not disclosed, so size versus revenue is unknown.

    Oct 30, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서

    Predicted impact: Low

    Oct 30, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)

    Predicted impact: Low

    Oct 30, 2026Open on DART
  • Share cancellation decision주식소각결정

    Predicted impact: Medium

    Share cancellation by subsidiary; size not given, so impact on parent uncertain.

    Oct 27, 2026Open on DART
  • Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)

    Predicted impact: Medium

    Preliminary consolidated results for a large holding company; no figures given to show a surprise versus last year.

    Oct 27, 2026Open on DART
  • Share cancellation decision주식소각결정(자회사의 주요경영사항)

    Predicted impact: Medium

    Share cancellation by subsidiary; size not given, so impact on parent uncertain.

    Oct 27, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최(안내공시)

    Predicted impact: Low

    Oct 16, 2026Open on DART
  • Advance Notice of Earnings Results Disclosure (Informational Disclosure)결산실적공시예고(안내공시)

    Predicted impact: Low

    Oct 16, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)

    Predicted impact: Low· Actual: −9.1% vs sector, volume 0.8× normal (5 trading days)

    Oct 16, 2026Open on DART
  • Change in largest shareholder's holdings최대주주등소유주식변동신고서

    Predicted impact: Low· Actual: −4.3% vs sector, volume 0.9× normal (5 trading days)

    Oct 15, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항(자회사의 주요경영사항) (에페오토인젝터주(에페글레나타이드) 식품의약품안전처 품목허가 승인)Oct 7, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Oct 7, 2026Open on DART
  • Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서Oct 7, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최(안내공시)Oct 2, 2026Open on DART
  • Withdrawal of Subsidiary from Holding Company지주회사의자회사탈퇴Sep 30, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항(자회사의 주요경영사항)Sep 29, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 29, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 23, 2026Open on DART
  • Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서Sep 23, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 11, 2026Open on DART
  • Change in largest shareholder's holdings최대주주등소유주식변동신고서Sep 1, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 1, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 1, 2026Open on DART
  • Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(자회사의 주요경영사항) (급성골수성백혈병(AML) 치료 항암신약 HM43239 기술이전 계약 체결)Aug 26, 2026Open on DART
  • Major management matter relevant to investors투자판단관련주요경영사항(자회사의 주요경영사항)Aug 24, 2026Open on DART
  • Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(자회사의 주요경영사항)Aug 21, 2026Open on DART
  • Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(자회사의 주요경영사항)Aug 21, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • Change in largest shareholder's holdings최대주주등소유주식변동신고서Aug 12, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 12, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Aug 12, 2026Open on DART
  • Change in largest shareholder's holdings최대주주등소유주식변동신고서Aug 11, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 11, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: Hanmi Science / 한미사이언스 / 008930 / KRX:008930

Source: KRX statistical information